171 related articles for article (PubMed ID: 34519693)
21. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
22. Identification of pathology-specific regulators of m
Li N; Zhan X
EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
[TBL] [Abstract][Full Text] [Related]
23. METTL3-mediated m
Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
[TBL] [Abstract][Full Text] [Related]
24. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
25. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
26. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
27. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
Zhang X; Cai X
Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
[TBL] [Abstract][Full Text] [Related]
28. Construction and validation of m
Miao Y; Su B; Tang X; Wang J; Quan W; Chen Y; Mi D
IET Syst Biol; 2022 Apr; 16(2):59-71. PubMed ID: 35174637
[TBL] [Abstract][Full Text] [Related]
29. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction.
Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C
J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306
[TBL] [Abstract][Full Text] [Related]
31. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
32. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease.
Qin L; Min S; Shu L; Pan H; Zhong J; Guo J; Sun Q; Yan X; Chen C; Tang B; Xu Q
Neurobiol Aging; 2020 Sep; 93():143.e9-143.e13. PubMed ID: 32371107
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Hu Z; Zhu L; Zhang Y; Chen B
Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
[TBL] [Abstract][Full Text] [Related]
35. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.
Jin H; Wu Z; Tan B; Liu Z; Zu Z; Wu X; Bi Y; Hu X
Bioengineered; 2022 Jun; 13(6):14595-14604. PubMed ID: 35758042
[TBL] [Abstract][Full Text] [Related]
36. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
[TBL] [Abstract][Full Text] [Related]
37. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
[TBL] [Abstract][Full Text] [Related]
39. Role of m6A modification in female infertility and reproductive system diseases.
Chen J; Fang Y; Xu Y; Sun H
Int J Biol Sci; 2022; 18(9):3592-3604. PubMed ID: 35813486
[TBL] [Abstract][Full Text] [Related]
40. Increased m6A-RNA methylation and demethylase FTO suppression is associated with silica-induced pulmonary inflammation and fibrosis.
Xu Y; Wang L; Qian R; Zhao M; Chen X; Sun D; Wang Y; Cheng W; Chen Y; He Q; Dai Y; Yao Y
Toxicology; 2023 Dec; 500():153673. PubMed ID: 37979906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
